| 1 |
Lin F, Zhang G, Yang X, Wang M, Wang R, Wan M, Wang J, Wu B, Yan T, Jia Y. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway. J Ethnopharmacol 2023;303:115933. [PMID: 36403742 DOI: 10.1016/j.jep.2022.115933] [Reference Citation Analysis]
|
| 2 |
Sehgal P, Chaturvedi P. Chromatin and Cancer: Implications of Disrupted Chromatin Organization in Tumorigenesis and Its Diversification. Cancers (Basel) 2023;15. [PMID: 36672415 DOI: 10.3390/cancers15020466] [Reference Citation Analysis]
|
| 3 |
Beato A, Della Torre L, Capone V, Carannante D, Favale G, Verrilli G, Altucci L, Carafa V. Epi-Regulation of Cell Death in Cancer. Cell Death and Disease [Working Title] 2022. [DOI: 10.5772/intechopen.108919] [Reference Citation Analysis]
|
| 4 |
Xu Y, Lei Z, Zhu J, Wan L. Mivebresib synergized with PZ703b, a novel Bcl-xl PROTAC degrader, induces apoptosis in bladder cancer cells via the mitochondrial pathway. Biochemical and Biophysical Research Communications 2022;623:120-6. [DOI: 10.1016/j.bbrc.2022.07.045] [Reference Citation Analysis]
|
| 5 |
Basha NJ, Basavarajaiah SM. An insight into therapeutic efficacy of heterocycles as histone-modifying enzyme inhibitors that targets cancer epigenetic pathways. Chem Biol Drug Des 2022. [PMID: 36059065 DOI: 10.1111/cbdd.14135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Dome A, Dymova M, Richter V, Stepanov G. Post-Transcriptional Modifications of RNA as Regulators of Apoptosis in Glioblastoma. IJMS 2022;23:9272. [DOI: 10.3390/ijms23169272] [Reference Citation Analysis]
|
| 7 |
Ozyerli-goknar E, Kala EY, Aksu AC, Bulut I, Cingöz A, Nizamuddin S, Biniossek M, Seker-polat F, Morova T, Aztekin C, Kung SH, Syed H, Tuncbag N, Gonen M, Philpott M, Cribbs AP, Acilan C, Lack NA, Onder TT, Timmers HM, Bagci-onder T. Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survival.. [DOI: 10.1101/2022.08.17.504245] [Reference Citation Analysis]
|
| 8 |
Ye B, Ma J, Li Z, Li Y, Han X. Ononin Shows Anticancer Activity Against Laryngeal Cancer via the Inhibition of ERK/JNK/p38 Signaling Pathway. Front Oncol 2022;12:939646. [DOI: 10.3389/fonc.2022.939646] [Reference Citation Analysis]
|
| 9 |
Liu B, Liu R, Liu Q, Ashby CR Jr, Zhang H, Chen ZS. The ethnomedicinal and functional uses, phytochemical and pharmacology of compounds from Ardisia species: An updated review. Med Res Rev 2022. [PMID: 35670013 DOI: 10.1002/med.21894] [Reference Citation Analysis]
|
| 10 |
Adhikari S, Bhattacharya A, Adhikary S, Singh V, Gadad SS, Roy S, Das C. The paradigm of drug resistance in cancer: an epigenetic perspective. Biosci Rep 2022;42:BSR20211812. [PMID: 35438143 DOI: 10.1042/BSR20211812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Liu J, Li JN, Wu H, Liu P. The Status and Prospects of Epigenetics in the Treatment of Lymphoma. Front Oncol 2022;12:874645. [PMID: 35463343 DOI: 10.3389/fonc.2022.874645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Xavier CP, Belisario DC, Rebelo R, Assaraf YG, Giovannetti E, Kopecka J, Vasconcelos MH. The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 13 |
Wang X, Mao H, Guan X, Huang Q, Yu Z, Wu J, Tan H, Zhang F, Huang X, Deng K, Xin H. TRIM65 Promotes Cervical Cancer Through Selectively Degrading p53-Mediated Inhibition of Autophagy and Apoptosis. Front Oncol 2022;12:853935. [DOI: 10.3389/fonc.2022.853935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Hu L, Li H, Zi M, Li W, Liu J, Yang Y, Zhou D, Kong QP, Zhang Y, He Y. Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development. Front Cell Dev Biol 2022;10:822816. [PMID: 35252191 DOI: 10.3389/fcell.2022.822816] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 15 |
Corsi F, Capradossi F, Pelliccia A, Briganti S, Bruni E, Traversa E, Torino F, Reichle A, Ghibelli L. Apoptosis as Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer. Int J Mol Sci 2022;23:1152. [PMID: 35163077 DOI: 10.3390/ijms23031152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 16 |
Martínez-Iglesias O, Carrera I, Naidoo V, Cacabelos R. AntiGan: An Epinutraceutical Bioproduct with Antitumor Properties in Cultured Cell Lines. Life (Basel) 2022;12:97. [PMID: 35054489 DOI: 10.3390/life12010097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Wu B, Zhang Y, Yu Y, Zhong C, Lang Q, Liang Z, Lv C, Xu F, Tian Y. Long Noncoding RNA H19: A Novel Therapeutic Target Emerging in Oncology Via Regulating Oncogenic Signaling Pathways. Front Cell Dev Biol 2021;9:796740. [PMID: 34977037 DOI: 10.3389/fcell.2021.796740] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Gonçalves AC, Richiardone E, Jorge J, Polónia B, Xavier CPR, Salaroglio IC, Riganti C, Vasconcelos MH, Corbet C, Sarmento-Ribeiro AB. Impact of cancer metabolism on therapy resistance - Clinical implications. Drug Resist Updat 2021;:100797. [PMID: 34955385 DOI: 10.1016/j.drup.2021.100797] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
|
